Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
US10738038B2 · kind B2 · utility
0Cited by
15References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2019 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Aug 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D407/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.